# Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

> **NCT01802268** · PHASE4 · COMPLETED · sponsor: **Helio Tedesco Silva Junior** · enrollment: 320 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Conversion from Tacrolimus to Sirolimus
- **DRUG:** Maintenance on tacrolimus

## Key facts

- **NCT ID:** NCT01802268
- **Lead sponsor:** Helio Tedesco Silva Junior
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2012-04
- **Final completion:** 2012-10
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2013-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01802268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01802268, "Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01802268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*